Cliff Asness's TWST Position Overview
Cliff Asness (via Aqr Capital Management LLC) currently holds 129,552 shares of Twist Bioscience Corporation (TWST) worth $4.11 M, representing 0.00% of the portfolio. First purchased in 2020-Q3, this medium-term investment has been held for 18 quarters.
Based on 13F filings, Cliff Asness has maintained a strategic position in TWST, demonstrating sustained confidence in this investment. Largest addition occurred in Q3 2024, adding 126,133 shares. Largest reduction occurred in Q2 2025, reducing 117,137 shares.
Analysis based on 13F filings available since 2013 Q2
Cliff Asness's Twist Bioscience Corporation (TWST) Holding Value Over Time
Track share changes against reported price movement
Quarterly Twist Bioscience Corporation (TWST) Trades by Cliff Asness
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | -78,356 | Reduce 37.69% | 129,552 | $31.72 |
| Q3 2025 | +59,396 | Add 39.99% | 207,908 | $28.14 |
| Q2 2025 | -117,137 | Reduce 44.09% | 148,512 | $36.79 |
| Q1 2025 | +104,875 | Add 65.23% | 265,649 | $39.26 |
| Q4 2024 | -26,787 | Reduce 14.28% | 160,774 | $46.47 |
| Q3 2024 | +126,133 | Add 205.33% | 187,561 | $45.18 |
| Q2 2024 | +28,027 | Add 83.91% | 61,428 | $49.28 |
| Q1 2024 | +33,401 | New Buy | 33,401 | $34.31 |
| Q3 2023 | -10,727 | Sold Out | 0 | $0.00 |
| Q2 2023 | -1,202 | Reduce 10.08% | 10,727 | $20.46 |
| Q1 2023 | +11,929 | New Buy | 11,929 | $15.08 |
| Q1 2022 | -3,483 | Sold Out | 0 | $0.00 |
| Q4 2021 | -11,793 | Reduce 77.20% | 3,483 | $77.52 |
| Q3 2021 | +1,584 | Add 11.57% | 15,276 | $106.97 |
| Q2 2021 | +1,801 | Add 15.15% | 13,692 | $133.22 |
| Q1 2021 | +4,689 | Add 65.11% | 11,891 | $123.88 |
| Q4 2020 | +2,225 | Add 44.71% | 7,202 | $141.35 |
| Q3 2020 | +4,977 | New Buy | 4,977 | $75.95 |
Cliff Asness's Twist Bioscience Corporation Investment FAQs
Cliff Asness first purchased Twist Bioscience Corporation (TWST) in Q3 2020, acquiring 4,977 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness has held Twist Bioscience Corporation (TWST) for 18 quarters since Q3 2020.
Cliff Asness's largest addition to Twist Bioscience Corporation (TWST) was in Q3 2024, adding 187,561 shares worth $8.47 M.
According to the latest 13F filing for Q4 2025, Cliff Asness's firm, Aqr Capital Management LLC, owns 129,552 shares of Twist Bioscience Corporation (TWST), valued at approximately $4.11 M.
As of the Q4 2025 filing, Twist Bioscience Corporation (TWST) represents approximately 0.00% of Cliff Asness's publicly disclosed stock portfolio, making it one of their key holdings.
Cliff Asness's peak holding in Twist Bioscience Corporation (TWST) was 265,649 shares, as reported at the end of Q1 2025.